Bayer HealthCare Pharmaceuticals Inc.

Bayer HealthCare Pharmaceuticals Inc., a specialty pharmaceutical company, develops, manufactures, and markets pharmaceutical products for diagnosing, preventing, and treating diseases for human health. The company focuses on women’s healthcare, diagnostic imaging, general medicine, hematology/neurology, and oncology products. It provides NEXAVAR, an anticancer medicine used to treat kidney cancer; Stivarga regorafenib tablets for the treatment of patients with metastatic colorectal cancer; Aflibercept (Eylea), an anti-angiogenic therapy for wAMD patients; Xofigo (radium Ra 223 dichloride), an alpha particle-emitting radioactive therapeutic agent for the treatment of patients with castration-resistant prostate cancer, symptomatic bone metastases, and visceral metastatic diseases; Gadavist, a gadolinium-based contrast agent for pediatric patients; and Dienogest to treat endometriosis in women. Bayer HealthCare Pharmaceuticals Inc. has a strategic alliance with Broad Institute. The company was founded in 1979 and is headquartered in Wayne, New Jersey. Bayer HealthCare Pharmaceuticals Inc. operates as a subsidiary of Bayer AG.